Actively Recruiting
The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit
Led by Yonsei University · Updated on 2022-06-13
10000
Participants Needed
1
Research Sites
517 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In the case of cardiogenic shock, the early mortality rate is the highest compared to other types of shock, but it is characterized by a good prognosis and quality of life after recovery, so monitoring the treatment progress is very important to identify the patient's prognosis. However, there are few studies specifically reported on hemodynamic monitoring and prognosis of cardiogenic shock. In addition, as mechanical circulatory support devices are in the spotlight, studies on their effects and safety are starting, but studies on cardiogenic shock are often limited to patients with myocardial infarction. This study is a prospective and retrospective cohort observational study, we aim to identify factors that can improve prognosis, including various drug treatments, diagnostic techniques, and mechanical circulatory support device by investigating the treatment status and clinical outcomes of patients with cardiogenic shock hospitalized in cardiovascular critical care unit. In addition, the purpose of this study is to investigate the association between the prognosis of patients with cardiogenic shock and the presence of a specialist resident during regular work hours to clarify the role and necessity of a resident specialist in the cardiovascular intensive care unit. Furthermore, by predicting and treating the clinical course of patients with cardiogenic shock at an early stage, the aim is to reduce the mortality rate and improve the patients' ability to perform daily activities.
CONDITIONS
Official Title
The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 19 years old
- Hospitalized in the cardiovascular critical care unit for cardiogenic shock or low blood pressure due to other causes
- Systolic blood pressure below 90 mmHg for at least 30 minutes despite fluid treatment or needing vasopressors to keep it above 90 mmHg
- Presence of at least one symptom of poor tissue perfusion such as cold skin, urine output below 30cc per hour, decreased consciousness, lactate over 2.0 mmol/l, or pulmonary edema
- Supported by mechanical circulatory support device
- Cardiogenic shock caused by interventions or surgeries related to coronary artery disease, peripheral artery disease, venous thromboembolism, pulmonary artery disease, aortic disease, valve disease, heart instrument insertion, ablation, defibrillator or pacemaker implantation, cardiac tamponade treatment, hypothermia therapy monitoring after circulation recovery, other heart-related procedures or surgeries, or heart transplant
- Patient or legal representative agrees to access medical records and study data during the entire study period
- Retrospective patients over 19 years old treated in the cardiovascular critical care unit from January 1, 2018 to IRB approval date for low blood pressure or intensive vital sign monitoring
You will not qualify if you...
- Patients with irreparable brain damage
- No witnesses present outside the hospital during cardiac arrest
- Do Not Resuscitate (DNR) patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yonsei University Health System, Severance Hospital
Seoul, South Korea
Actively Recruiting
Research Team
C
Chul-Min Ahn
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here